Durant el mes de juny, organitzem tres activitats sobre assaigs clínics, genètica i imatges científiques.

El director del programa ECMO de Vall d’Hebron va participar en la darrera edició del congrés EuroELSO, que va celebrar-se a Londres aquest mes de maig.

The study showing how thrombocytopenia increases the risk of thrombosis in patients with antiphospholipid syndrome has been considered the best paper published in 2021.

Aquesta trobada es dirigeix a un públic de totes les edats amb un ampli ventall de formats: experiments, instal·lacions, jocs, tallers, demostracions, espectacles, debats, microxerrades, itineraris i visites guiades, entre d’altres.

The identification of genetic alterations is key to be able to administer targeted therapies to each patient.

EXIMIOUS is a project funded by the Horizon 2020 program that aims to study the exposome to understand its relationship with immune-mediated diseases.

Un total de 2.873 pacients van participar en els assaigs clínics que Vall d’Hebron va fer l’any 2021, un any en què es van posar en marxa 443 assaigs nous. 

EU-PEARL hopes to transform standard clinical trials into collaborative multi-compound research platforms focused on patients.

The head of the Medical Molecular Imaging group at VHIR received the recognition for the best poster presentation for a study on myocardial insulin resistance and cardiovascular risk.

For two days, 30 people between Hepatologia¡ unit researchers and industry experts have laid the foundations for this project.

VHIR collaborates with Nanbiosis through the FVPR service platform created within the Drug Delivery and Targeting Research Group (DTT).

BSC coordinates QUSTom, the first project that will use supercomputing to detect tumors more effectively and safely.

H2O és el primer projecte en l’àmbit europeu a gran escala que recopilarà i incorporarà els resultats dels i de les pacients de manera sistemàtica en la presa de decisions d'atenció mèdica.

En el Dia Internacional de la Infermeria fem valdre la figura del professional de la infermeria especialitzat, amb capacitat per prendre decisions complexes i formació per exercir la docència, la recerca i millorar la seguretat del pacient.

Researchers at Vall d'Hebron have established a simple algorithm of recommendations for taking the arterial pulse, a rapid and non-invasive method for identifying patients with atrial fibrillation, a type of arrhythmia that increases the risk of stroke.

És una iniciativa infermera de l’àrea de coneixement del Pacient Fràgil Traumàtic, ideada per minimitzar les interrupcions durant aquest procediment.

In a meeting held on May 5 and 6, researchers from Vall d'Hebron and the Italian center have exchanged knowledge to collaborate in different areas of research.

The composition of gut microbiota is unique, like our fingerprints.

Vall d’Hebron was one of the study promoters, which determined the most effective transfer circuits for patients with severe stroke.

An international clinical trial has demonstrated the effectiveness of dupilumab in reducing patients’ asthmatic exacerbations, improving their and their relatives quality of life

During the session, the first call for an intensification grant coordinated by Vall d’Hebron was announced, which will make it easier for nurses to participate in research projects.

The knowledge of these mechanisms will help to develop pharmacological strategies to prevent heart failure associated with aging.

The Centre, spanning a total surface area of 1,400 m2, has a High Complexity Area with replicas of a critical care unit, A&E department, outpatients clinic and operating theatre using state-of-the-art virtual reality.

Amb l’esmorzar, s’entregaran als i a les pacients un sobre amb una “rosa feta de tot cor”, un post-it en forma de cor, un llibre i un punt de llibre. Els post-its estan pensats perquè puguin escriure un agraïment per al personal sanitari.